Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.

about

Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.

Item

http://www.wikidata.org/entity/Q40854812

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Prophylaxis therapy in paediat ...... al management trends in Italy.

@en

type

Item

label

Prophylaxis therapy in paediat ...... al management trends in Italy.

@en

prefLabel

Prophylaxis therapy in paediat ...... al management trends in Italy.

@en

P1476

Prophylaxis therapy in paediat ...... cal management trends in Italy

@en

P2093

Angiola Rocino

http://www.w3.org/2001/XMLSchema#string

Ezio Zanon

http://www.w3.org/2001/XMLSchema#string

Fabio Gagliano

http://www.w3.org/2001/XMLSchema#string

Giancarlo Castaman

http://www.w3.org/2001/XMLSchema#string

M Gabriella Mazzucconi

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Inherited bleeding disorders: results from the Italian Regional Haemophilia Centre of Pescara.

Haemophilia care in adolescents--compliance and lifestyle issues.

A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A.

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.

Identifying non-responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition.

Diagnosis and management of haemophilia.

Health status and health-related quality of life associated with hemophilia.

Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study.

Effects of secondary prophylaxis started in adolescent and adult haemophiliacs.

P304

631-638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2450/2015.0333-14

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Angelo Claudio Molinari

P577

2015-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277958221

http://www.w3.org/2001/XMLSchema#string

P698

26057481

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

An Eadailt

P932

4624540

http://www.w3.org/2001/XMLSchema#string